Tuesday, November 29, 2016

6 High-Yielding Dividend Achievers With Good Financial Ratios

I've often said that dividend stocks are the foundation of a great retirement portfolio -- and for good reason. For starters, companies that pay dividends usually have a long history of profitability and a sound long-term outlook. 

A business that doesn't have a clear path to growth typically isn't going to pay a dividend. In other words, buying dividend stocks often means buying into high-quality, profitable companies with long histories of success.

Secondly, dividend stocks can help hedge the stock market's inevitable moves lower. Since 1950, the S&P 500 has corrected lower by at least 10% (when rounded to the nearest digit) on 35 occasions.

Owning dividend stocks is a great way to help hedge against these market swoons. As an added bonus, since dividend stocks tend to attract long-term investors, they can sometimes also be far less volatile during corrections.

Lastly, dividend stocks give you the ability to take advantage of compounding over time by reinvesting your payout back into more shares. Doing so allows your ownership in a business to grow, as well as your corresponding payout. Compounding is a tactic some of the smartest money managers use to increase the value of their funds over time.

But some of the best dividend stocks can be found floating well below investors' radars. Attached you will find three high-yield bargain dividend stocks you've probably been overlooking this fall. Every of the results has a dividend yield over 4% and a debt-to-equity below one.

These are the results...

GlaxoSmithKline -- Yield: 5.20%

GlaxoSmithKline (NYSE:GSK) employs 101,192 people, generates revenue of $29,415.81 million and has a net income of $10,294.24 million. The current market capitalization stands at $96.88 billion.

GlaxoSmithKline’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,423.68 million. The EBITDA margin is 32.04% (the operating margin is 46.67% and the net profit margin 35.00%).

Financials: The total debt represents 31.12% of GlaxoSmithKline assets and the total debt in relation to the equity amounts to 325.22%. Due to the financial situation, a return on equity of 179.63% was realized by GlaxoSmithKline.

Twelve trailing months earnings per share reached a value of $0.15. Last fiscal year, GlaxoSmithKline paid $1.97 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 275.25, the P/S ratio is 3.37 and the P/B ratio is finally 16.16. The dividend yield amounts to 5.20%.

Stock Charts:

Long-Term Stock Price Chart of GlaxoSmithKline (GSK)
Long-Term Stock Price Chart of GlaxoSmithKline (GSK)
Long-Term Dividend Payment History of GlaxoSmithKline (GSK)
Long-Term Dividend Payment History of GlaxoSmithKline (GSK)
Long-Term Dividend Yield History of GlaxoSmithKline (GSK)
Long-Term Dividend Yield History of GlaxoSmithKline (GSK)


National Health Investors -- Yield: 4.60%

National Health Investors (NYSE:NHI) employs people, generates revenue of $228.99 million and has a net income of $150.31 million. The current market capitalization stands at $2.94 billion.

National Health Investors’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $220.49 million. The EBITDA margin is 96.29% (the operating margin is 55.34% and the net profit margin 65.64%).

Financials: The total debt represents 42.87% of National Health Investors assets and the total debt in relation to the equity amounts to 80.69%. Due to the financial situation, a return on equity of 13.70% was realized by National Health Investors.

Twelve trailing months earnings per share reached a value of $4.34. Last fiscal year, National Health Investors paid $3.40 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.27, the P/S ratio is 13.38 and the P/B ratio is finally 2.65. The dividend yield amounts to 4.60%.

Stock Charts:

Long-Term Stock Price Chart of National Health Investors (NHI)
Long-Term Stock Price Chart of National Health Investors (NHI)
Long-Term Dividend Payment History of National Health Investors (NHI)
Long-Term Dividend Payment History of National Health Investors (NHI)
Long-Term Dividend Yield History of National Health Investors (NHI)
Long-Term Dividend Yield History of National Health Investors (NHI)


Mercury General -- Yield: 4.59%

Mercury General (NYSE:MCY) employs 4,300 people, generates revenue of $3,009.30 million and has a net income of $74.48 million. The current market capitalization stands at $2.78 billion.

Mercury General’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $639.47 million. The EBITDA margin is 21.25% (the operating margin is 2.45% and the net profit margin 2.47%).

Financials: The total debt represents 6.27% of Mercury General assets and the total debt in relation to the equity amounts to 15.93%. Due to the financial situation, a return on equity of 4.03% was realized by Mercury General.

Twelve trailing months earnings per share reached a value of $2.01. Last fiscal year, Mercury General paid $2.47 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 25.43, the P/S ratio is 0.99 and the P/B ratio is finally 1.64. The dividend yield amounts to 4.59%.

Stock Charts:

Long-Term Stock Price Chart of Mercury General (MCY)
Long-Term Stock Price Chart of Mercury General (MCY)
Long-Term Dividend Payment History of Mercury General (MCY)
Long-Term Dividend Payment History of Mercury General (MCY)
Long-Term Dividend Yield History of Mercury General (MCY)
Long-Term Dividend Yield History of Mercury General (MCY)


Chevron Corporation -- Yield: 4.20%

Chevron Corporation (NYSE:CVX) employs 61,500 people, generates revenue of $129,648.00 million and has a net income of $4,710.00 million. The current market capitalization stands at $189.29 billion.

Chevron Corporation’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $20,951.00 million. The EBITDA margin is 16.16% (the operating margin is -0.07% and the net profit margin 3.63%).

Financials: The total debt represents 14.57% of Chevron Corporation assets and the total debt in relation to the equity amounts to 25.24%. Due to the financial situation, a return on equity of 2.98% was realized by Chevron Corporation.

Twelve trailing months earnings per share reached a value of $-0.40. Last fiscal year, Chevron Corporation paid $4.28 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is , the P/S ratio is 1.48 and the P/B ratio is finally 1.25. The dividend yield amounts to 4.20%.

Stock Charts:

Long-Term Stock Price Chart of Chevron Corporation (CVX)
Long-Term Stock Price Chart of Chevron Corporation (CVX)
Long-Term Dividend Payment History of Chevron Corporation (CVX)
Long-Term Dividend Payment History of Chevron Corporation (CVX)
Long-Term Dividend Yield History of Chevron Corporation (CVX)
Long-Term Dividend Yield History of Chevron Corporation (CVX)


Flowers Foods -- Yield: 4.14%

Flowers Foods (NYSE:FLO) employs 10,900 people, generates revenue of $3,778.50 million and has a net income of $189.19 million. The current market capitalization stands at $3.13 billion.

Flowers Foods’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $433.85 million. The EBITDA margin is 11.48% (the operating margin is 7.88% and the net profit margin 5.01%).

Financials: The total debt represents 35.33% of Flowers Foods assets and the total debt in relation to the equity amounts to 80.82%. Due to the financial situation, a return on equity of 15.99% was realized by Flowers Foods.

Twelve trailing months earnings per share reached a value of $0.88. Last fiscal year, Flowers Foods paid $0.57 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.44, the P/S ratio is 0.85 and the P/B ratio is finally 2.64. The dividend yield amounts to 4.14%.

Stock Charts:

Long-Term Stock Price Chart of Flowers Foods (FLO)
Long-Term Stock Price Chart of Flowers Foods (FLO)
Long-Term Dividend Payment History of Flowers Foods (FLO)
Long-Term Dividend Payment History of Flowers Foods (FLO)
Long-Term Dividend Yield History of Flowers Foods (FLO)
Long-Term Dividend Yield History of Flowers Foods (FLO)


Realty Income -- Yield: 3.87%

Realty Income (NYSE:O) employs 133 people, generates revenue of $1,023.28 million and has a net income of $284.86 million. The current market capitalization stands at $15.93 billion.

Realty Income’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $919.55 million. The EBITDA margin is 89.86% (the operating margin is 25.97% and the net profit margin 27.84%).

Financials: The total debt represents 40.74% of Realty Income assets and the total debt in relation to the equity amounts to 73.88%. Due to the financial situation, a return on equity of 4.52% was realized by Realty Income.

Twelve trailing months earnings per share reached a value of $1.09. Last fiscal year, Realty Income paid $2.27 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 56.54, the P/S ratio is 15.83 and the P/B ratio is finally 2.56. The dividend yield amounts to 3.87%.

Stock Charts:

Long-Term Stock Price Chart of Realty Income (O)
Long-Term Stock Price Chart of Realty Income (O)
Long-Term Dividend Payment History of Realty Income (O)
Long-Term Dividend Payment History of Realty Income (O)
Long-Term Dividend Yield History of Realty Income (O)
Long-Term Dividend Yield History of Realty Income (O)

This article was written by Dividend Yield. If you enjoyed this article, please subscribe to his feed [RSS].

0 comments:

Post a Comment

Recent Posts From DIV-Net Members